Pneumocystis Jiroveci PneumoniaSymptoms, Doctors, Treatments, Advances & More
Learn About Pneumocystis Jiroveci Pneumonia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of California San Francisco
Laurence Huang is an Intensive Care Medicine provider practicing medicine in San Francisco, California. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, Pulmonary Tuberculosis, Lung Metastases, and Endoscopy.
University Medical Center
Judd Shellito is a Pulmonary Medicine provider practicing medicine in New Orleans, Louisiana. Dr. Shellito is rated as an Elite provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), and Lung Metastases.
Mayo Clinic-Rochester
Andrew Limper is a Pulmonary Medicine provider practicing medicine in Virginia Beach, Virginia. Dr. Limper is rated as an Elite provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis.
Summary: Pneumocystis jirovecii pneumonia (PCP) is an opportunistic fungal infection of immunocompromised hosts which causes in significant morbidity and mortality. The current standard of care, trimethoprim-sulfamethoxazole (TMP-SMX) at a dose of 15-20 mg/kg/day of TMP, is associated with serious adverse events, including hypersensitivity reactions, drug-induced liver injury, cytopenia, and renal failure ...
Summary: Renal transplantation is the most ideal and effective treatment for end-stage renal disease. Pneumocystis jirovecii pneumonia (PJP) is one of the most common pulmonary infections after renal transplantation, with high morbidity and mortality that seriously affects patients' prognosis and survival. PJP can be prevented with drugs, and trimethoprim-sulfamethoxazole (TMP-SMX) is the first-choice prop...